Gene: IFTAP
Official Full Name: intraflagellar transport associated proteinprovided by HGNC
Gene Summary: This gene encodes a protein that was identified as a cellular interacting partner of non-structural protein 10 of the severe acute respiratory syndrome coronavirus (SARS-CoV). The encoded protein may function as a negative regulator of transcription. There is a pseudogene for this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30359 | IFTAP Knockout cell line (HeLa) | Human | IFTAP | 1:3~1:6 | Negative | Online Inquiry |
KO30360 | IFTAP Knockout cell line (HCT 116) | Human | IFTAP | 1:2~1:4 | Negative | Online Inquiry |
KO30361 | IFTAP Knockout cell line (HEK293) | Human | IFTAP | 1:3~1:6 | Negative | Online Inquiry |
KO30362 | IFTAP Knockout cell line (A549) | Human | IFTAP | 1:3~1:4 | Negative | Online Inquiry |
IFTAP Gene Knockout Cell Lines are specialized, genetically engineered cell models designed to facilitate the comprehensive study of the IFTAP gene. This product utilizes CRISPR-Cas9 technology, a state-of-the-art gene-editing tool, to create defined knockouts of the IFTAP gene, which encodes proteins implicated in intraflagellar transport—an essential process for cilium formation and function in various higher eukaryotic cells. The precise knockout allows researchers to investigate the role of IFTAP in cellular signaling pathways, ciliary structure and cellular responses to microenvironmental changes.
The key mechanism behind IFTAP Gene Knockout Cell Lines is the targeted disruption of the IFTAP gene sequence, enabling the analysis of downstream effects on cellular behavior. Through loss-of-function studies, researchers can elucidate the gene's contribution to ciliary biogenesis, as well as its implications in diseases associated with ciliary dysfunction, such as Bardet-Biedl syndrome and primary ciliopathies. This demonstrates the product’s significance within both basic research and preclinical studies.
A major advantage of IFTAP Gene Knockout Cell Lines over traditional models is their reproducibility and accessibility to high-throughput screening applications. These models come validated and characterized, allowing for reliable experimental designs without the need for extensive preliminary work. Additionally, they provide a more precise genetic editing outcome compared to alternatives like RNA interference, which may yield off-target effects or incomplete gene silencing.
For researchers and clinicians focused on understanding the nuances of ciliary function and related disorders, IFTAP Gene Knockout Cell Lines represent a valuable asset, enabling breakthroughs in both diagnostics and therapeutics. By integrating these advanced cell lines into their assays, users can significantly enhance the relevance and accuracy of their findings, accelerating scientific discovery in the field.
Our company specializes in delivering high-quality biological tools and innovative solutions for life science research. Committed to excellence, we provide researchers with the resources they need to advance their understanding of complex biological systems effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.